Skip to content
Archive

KOLINPHARMA® has presented Declinex®, launching its new line of products dedicated to neurodegenerative diseases.

Thanks to active components such as green tea dry extract standardised in epigallocatechin gallate, saffron dry extract, trans-resveratrol (Veri-te®), citicoline (Cognizin®), zinc and other specific micronutrients, Declinex® aims to support mental well-being, improve mood and provide targeted antioxidant action.

Read the press release

More news

  1. Kolinpharma® for gender equality at PMIHeroes
  2. KOLINPHARMA®: first patent obtained for Xinprox®
  3. KOLINPHARMA® signs an agreement with ASTAREAL® AB to distribute its products in the Asian market
Archive